Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

Jorge Cortes*, Susan O'Brien, Alfonso Quintas, Francis Giles, Jianquin Shan, Mary Beth Rios, Moshe Talpaz, Hagop Kantarjian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase'. Together they form a unique fingerprint.

Medicine & Life Sciences